Search Options Stock News and Analysis from Schaeffer's

FDA Rejection Pushes Incyte Stock Sharply Lower

https://www.schaeffersresearch.com/content/news/2023/03/24/fda-rejection-pushes-incyte-stock-sharply-lower

3/24/2023 11:05 AM

The shares of Incyte Corporation ( NASDAQ:INCY) are down 5.3% at $68.33 at last check, after the U.S. Food and Drug Administration (FDA) failed to approve the extended-release version of the compan...

Incyte Stock Dips Despite Dermatitis Drug Buzz

https://www.schaeffersresearch.com/content/news/2019/02/04/incyte-stock-dips-despite-dermatitis-drug-buzz

2/4/2019 10:32 AM

The shares of Incyte Corporation (NADSAQ:INCY) were pointed higher in pre-market trading, after the company's experimental atopic dermatitis treatment met the main goal in two late-stage studies. The...

https://www.schaeffersresearch.com/content/options/2018/10/19/calls-popular-as-incyte-stock-cheers-cancer-drug-data

10/19/2018 2:19 PM

Earlier today, Incyte Corporation (NASDAQ:INCY) reported upbeat results from its mid-stage study of Capmatinib, the company's lung cancer treatment sponsored by Novartis (NOVN). Incyte Corporation sa...

2 Healthcare Stocks That Could Bounce Back Next Week

https://www.schaeffersresearch.com/content/analysis/2018/10/12/2-healthcare-stocks-that-could-bounce-back-next-week

10/12/2018 2:20 PM

Stocks earlier this week were clobbered, turning in their worst day in months. However, many individual stocks have flashed bullish signals in the wake of the bloodbath. If past is precedent, two heal...

2 Drug Stocks Slammed By FDA

https://www.schaeffersresearch.com/content/news/2018/04/24/2-drug-stocks-slammed-by-fda

4/24/2018 10:32 AM

The shares of drugmakers Incyte Corporation (NASDAQ:INCY) and Epizyme Inc (NASDAQ:EPZM) are getting crushed this morning, as the stocks react to Food and Drug Administration (FDA) buzz. What's mor...

PEOPLE ALSO SEARCH FOR